Q2 2019 Earnings Estimate for Smith & Nephew plc (SNN) Issued By Northcoast Research

Smith & Nephew plc (NYSE:SNN) – Northcoast Research upped their Q2 2019 earnings estimates for Smith & Nephew in a research note issued to investors on Monday, February 11th. Northcoast Research analyst D. Keiser now anticipates that the medical equipment provider will earn $0.92 per share for the quarter, up from their previous forecast of $0.90. Northcoast Research also issued estimates for Smith & Nephew’s Q1 2020 earnings at $0.00 EPS, Q2 2020 earnings at $0.98 EPS, Q3 2020 earnings at $0.00 EPS, Q4 2020 earnings at $1.20 EPS and FY2020 earnings at $2.18 EPS.

Several other equities analysts have also issued reports on the company. Morgan Stanley raised Smith & Nephew from an “equal weight” rating to an “overweight” rating in a research report on Monday, December 10th. Zacks Investment Research lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, January 2nd. JPMorgan Chase & Co. lowered Smith & Nephew from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 1st. Canaccord Genuity reaffirmed a “buy” rating on shares of Smith & Nephew in a research report on Thursday, November 1st. Finally, Deutsche Bank raised Smith & Nephew from a “sell” rating to a “hold” rating in a research report on Friday, December 7th. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $42.00.

SNN opened at $38.31 on Tuesday. The company has a quick ratio of 1.15, a current ratio of 2.10 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $17.58 billion, a PE ratio of 18.97, a P/E/G ratio of 3.07 and a beta of 0.48. Smith & Nephew has a 1 year low of $32.22 and a 1 year high of $40.78.

A number of large investors have recently modified their holdings of the business. Citigroup Inc. raised its position in Smith & Nephew by 0.5% in the 4th quarter. Citigroup Inc. now owns 52,113 shares of the medical equipment provider’s stock worth $1,947,000 after buying an additional 261 shares during the last quarter. Scotia Capital Inc. raised its position in Smith & Nephew by 5.3% in the 4th quarter. Scotia Capital Inc. now owns 6,639 shares of the medical equipment provider’s stock worth $248,000 after buying an additional 336 shares during the last quarter. Commonwealth Equity Services LLC raised its position in Smith & Nephew by 3.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 11,678 shares of the medical equipment provider’s stock worth $436,000 after buying an additional 432 shares during the last quarter. Eaton Vance Management raised its position in Smith & Nephew by 14.4% in the 4th quarter. Eaton Vance Management now owns 6,472 shares of the medical equipment provider’s stock worth $242,000 after buying an additional 815 shares during the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its position in Smith & Nephew by 32.1% in the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 3,373 shares of the medical equipment provider’s stock worth $120,000 after buying an additional 819 shares during the last quarter. 8.92% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew Company Profile

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Recommended Story: What are the benefits of buying treasury bonds?

Earnings History and Estimates for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply